Click to expand

Language pair: Click to swap content  Subject   

You searched for: chromogen    [ Turn off colors ]

Human contributions

From professional translators, enterprises, web pages and freely available translation repositories.

Add a translation

English

Spanish

Info

Substrate and chromogen:

Sustrato y cromógeno:

Last Update: 2009-01-01
Subject: Social Science
Usage Frequency: 1
Quality:
Reference: Translated.net

Add substrate and chromogen as described previously.

Añadir el substrato y el cromógeno del modo expuesto anteriormente.

Last Update: 2009-01-01
Subject: Social Science
Usage Frequency: 1
Quality:
Reference: Translated.net

The chromogen includes, but not limited to, potassium iodide, tetramethylbenzidine, N-(3-sulfopropyl)3,3',5,5'-sodium tetramethylbenzidine, 4-aminoantipyrine, and O-tolidine.

Entre los cromógenos se pueden citar, sin limitación, el yoduro de potasio, la tetrametilbenzidina, la N-(3-sulfopropil)-3,3',5,5'-tetrametilbenzidina de sodio, la 4-aminoantipirina, y la O-tolidina.

Last Update: 2008-02-08
Subject: Legal and Notarial
Usage Frequency: 1
Quality:
Reference: Mig_2k

In the test paper method, for example, hydrogen peroxide is generated by oxidase and reacted to peroxidase to generate active oxygen, and the active oxygen causes the oxidation of chromogen for coloration, the intensity of which may be observed.

En el procedimiento del papel reactivo, por ejemplo, se genera peróxido de hidrógeno por acción de una oxidasa y se hace reaccionar con peroxidasa para generar oxígeno activo, y a continuación el oxígeno activo provoca la oxidación de un cromógeno para conseguir coloración, cuya intensidad se puede observar.

Last Update: 2008-02-08
Subject: Legal and Notarial
Usage Frequency: 1
Quality:
Reference: Mig_2k

The specific cytokeratin 19 antibody bound to substrate is identified by using the alkaline phosphatase dextran- anti- mouse complex (<PROTECTED> <PROTECTED>/<PROTECTED> system <PROTECTED>) and <PROTECTED> rED TR/ <PROTECTED> AS- MX (<PROTECTED> <PROTECTED>; <PROTECTED> <PROTECTED> Co.) as chromogen.

El anticuerpo específico de citoqueratina 19 unido al sustrato se identifica mediante el complejo antirratón de dextrano conjugado con fosfatasa alcalina (sistema <PROTECTED> <PROTECTED>/<PROTECTED> de <PROTECTED>) y <PROTECTED> rED TR/ <PROTECTED> AS-MX (<PROTECTED> <PROTECTED>; <PROTECTED> <PROTECTED> Co.) como cromógeno.

Last Update: 2008-08-12
Subject: Legal and Notarial
Usage Frequency: 1
Quality:
Reference: Mig_2k
Warning: Contains invisible HTML formatting

The specific cytokeratin 3 antibody bounded to the substrate is identified by using the <PROTECTED>- dextran- antimouse complex (<PROTECTED> <PROTECTED>/<PROTECTED> system <PROTECTED>) and 3,3’- diaminobenzidine tetrachlorate (<PROTECTED> <PROTECTED>; <PROTECTED> <PROTECTED> Co.) as chromogen.

El anticuerpo específico de citoqueratina 3 unido al sustrato se identifica mediante el complejo antirratón <PROTECTED>-dextrano (sistema <PROTECTED> <PROTECTED>/<PROTECTED> de <PROTECTED>) y tetraclorato de 3,3’-diaminobenzidina (<PROTECTED> <PROTECTED>; <PROTECTED> <PROTECTED> Co.) como cromógeno.

Last Update: 2008-08-12
Subject: Legal and Notarial
Usage Frequency: 1
Quality:
Reference: Mig_2k
Warning: Contains invisible HTML formatting

Its activity is measured in a chromogenic assay.

Su actividad se determina mediante análisis cromogénico.

Last Update: 2008-03-04
Subject: Medical
Usage Frequency: 3
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.

In additional clinical studies, pharmacokinetic parameters measured using the chromogenic assay were determined for previously treated patients (PTPs) and previously untreated patients (PUPs) .

Los parámetros farmacocinéticos se determinaron en otros estudios clínicos mediante el método cromogénico en los pacientes tratados previamente (PTP) y en los no tratados previamente (PNTP) .

Last Update: 2008-03-04
Subject: Medical
Usage Frequency: 4
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.

The labelled potency of ReFacto is based on the European Pharmacopoeial chromogenic substrate assay.

La potencia declarada de Refacto se basa en el ensayo de sustrato cromogénico de la Farmacopea Europea.

Last Update: 2008-03-04
Subject: Medical
Usage Frequency: 4
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.

With ReFacto, the chromogenic assay yields results which are higher than the results obtained with the one-stage clotting assay.

Con ReFacto, el ensayo cromogénico proporciona resultados que son superiores a los obtenidos con el ensayo de coagulación en una fase.

Last Update: 2008-03-04
Subject: Medical
Usage Frequency: 4
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.

26 When monitoring patients'factor VIII activity levels during treatment, it is strongly recommended that the European Pharmacopoeial chromogenic substrate assay be used.

27 Cuando se monitorizan los niveles de actividad de factor VIII recombinante de los pacientes durante el tratamiento, se recomienda encarecidamente que se utilice el ensayo de sustrato cromogénico de la Farmacopea Europea.

Last Update: 2008-03-04
Subject: Medical
Usage Frequency: 4
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.

The potency (IU) is determined using the European Pharmacopoeial chromogenic assay.
http://www.emea.europa.eu/

La potencia (UI) se determina utilizando el ensayo cromogénico de la Farmacopea Europea.
http://www.emea.europa.eu/

Last Update: 2012-04-10
Subject: Pharmaceuticals
Usage Frequency: 2
Quality:

The protein C plasma activity was measured by chromogenic assay.
http://www.emea.europa.eu/

La actividad plasmática de la proteína C se midió mediante ensayo cromogénico.
http://www.emea.europa.eu/

Last Update: 2012-04-10
Subject: Pharmaceuticals
Usage Frequency: 3
Quality:

32 The labelled potency of ReFacto AF is based on the European Pharmacopoeial chromogenic substrate assay, in which the manufacturing potency standard has been calibrated to the WHO International Standard using the chromogenic substrate assay.
http://www.emea.europa.eu/

La potencia declarada de ReFacto AF se basa en el ensayo de sustrato cromogénico de la Farmacopea Europea, por lo que el estándar de potencia se ha calibrado frente al Patrón Internacional de la OMS mediante el ensayo del sustrato cromogénico.
http://www.emea.europa.eu/

Last Update: 2012-04-10
Subject: Pharmaceuticals
Usage Frequency: 2
Quality:

Strong recommendation to use the chromogenic substrate assay when monitoring patients.
http://www.emea.europa.eu/

Recomendación encarecida de utilizar el ensayo del sustrato cromogénico para el control de los pacientes.
http://www.emea.europa.eu/

Last Update: 2012-04-10
Subject: Pharmaceuticals
Usage Frequency: 2
Quality:

When monitoring patients' factor VIII activity levels during treatment with ReFacto AF, use of the European Pharmacopoeial chromogenic substrate assay is strongly recommended.
http://www.emea.europa.eu/

Cuando se monitorizan los niveles de actividad de factor VIII de los pacientes durante el tratamiento con ReFacto AF, se recomienda encarecidamente el empleo del ensayo del sustrato cromogénico de la Farmacopea Europea.
http://www.emea.europa.eu/

Last Update: 2012-04-10
Subject: Pharmaceuticals
Usage Frequency: 1
Quality:

In PUPs, pharmacokinetic parameters of ReFacto were evaluated using the chromogenic assay.
http://www.emea.europa.eu/

Se determinaron los parámetros farmacocinéticos de ReFacto utilizando el ensayo cromogénico en pacientes no tratados previamente (PNTP).
http://www.emea.europa.eu/

Last Update: 2012-04-10
Subject: Pharmaceuticals
Usage Frequency: 1
Quality:

The potency (IU) is determined using the European Pharmacopoeia chromogenic assay.

La potencia (UI) se determina utilizando el ensayo cromogénico de la Farmacopea Europea.

Last Update: 2008-03-04
Subject: Medical
Usage Frequency: 4
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.

* The potency (International Units) is determined using the European Pharmacopoeia chromogenic assay.
http://www.emea.europa.eu/

* La potencia (Unidades Internacionales) se determina utilizando el ensayo cromogénico de la Farmacopea Europea.
http://www.emea.europa.eu/

Last Update: 2012-04-10
Subject: Pharmaceuticals
Usage Frequency: 1
Quality:

When monitoring patients' factor VIII activity levels during treatment with ReFacto AF, use of the European Pharmacopoeial chromogenic substrate assay is strongly recommended.
http://www.emea.europa.eu/

La potencia declarada de ReFacto AF se basa en el ensayo de sustrato cromogénico de la Farmacopea Europea, por lo que el estándar de potencia se ha calibrado frente al Patrón Internacional de la OMS mediante el ensayo del sustrato cromogénico.
http://www.emea.europa.eu/

Last Update: 2012-04-10
Subject: Pharmaceuticals
Usage Frequency: 1
Quality:

Add a translation

Search human translated sentences

Credits - Computer translations are provided by a combination of our statistical machine translator, Google, Systran and Worldlingo.


Help rating similar searches:  tetramethylbenzidine (English - Spanish) | diaminobenzidine (English - Spanish) | aminoantipyrine (English - Spanish) | recommendation (English - Spanish)


Users are now asking for help: jeddah (English>Malay) | توائم (Arabic>Italian) | respaldada (Spanish>Italian) | neutrone (Italian>English) | gedi (Panjabi>Hindi) | zudecken (German>Thai) | votre correspondance (French>English) | referencedokument (Danish>Portuguese) | ετικέτα (Greek>Estonian) | cortesia e disponibilità (Italian>English) | пигменти (Bulgarian>English) | احتاج (Arabic>Dutch) | sisi (Spanish>Italian) | suavemente besame (>) | 电脑配置 (Chinese (Simplified)>Japanese)


Report Abuse  | About MyMemory   | Contact Us


MyMemory in your language: English  | ItalianoEspañolFrançaisDeutschPortuguêsРусский日本語汉语